开发日本特定的HL7FHIR与药物相关的个人资料
Shinji Kobayashi1,2, Masahiko Kimura3,4, Yoshinori Kodama5,4
1Gifu University, Gifu, Japan. kobayashi.shinji.k6@f.gifu-u.ac.jp.
Journal of medical systems
|April 8, 2025
概括
日本 日本 日本 日本 日本.
科学领域:
- 医疗信息学 医疗信息学
- 数字健康标准 数字健康标准
- 医疗保健互操作性 医疗保健互操作性
背景情况:
- 全球采用HL7快速医疗互操作性资源 (FHIR) 需要本地化实施指南.
- 日本的NeXEHRS学术研究小组开发了JP Core,这是其医疗保健系统的FHIR实施指南.
- JP Core v1.2.0 增强了日本处方工作流程与当地术语.
研究的目的:
- 分析日本JP Core FHIR实施指南的演变和整合情况.
- 评估日本FHIR的治理,并将其与国际模型进行比较.
- 确定挑战,并为日本未来的FHIR实施提供建议.
主要方法:
- 对JP Core v1.2.0的分析,重点关注药物概况和扩展.
- 检查过渡到GitHub和开发的寿司框架.
- 审查日本,美国和欧洲的FHIR治理结构.
主要成果:
- JP Core v1.2.0包括8个药物配置文件和23个扩展,包含日本术语 (HOT,YJ代码).
- 转向GitHub和Sushi框架改善了协作和标准化.
- 日本缺乏与国际标准相提并论的正式FHIR治理框架.
结论:
- JP Core 促进了日本电子处方的互操作性,但需要正式的治理.
- 建议包括建立一个国家治理机构,并将术语与国际标准保持一致,如SNOMED CT.
- 将JP核心与IPS和欧盟电子卫生指南等全球框架保持一致,对于未来的互操作性至关重要.
更多相关视频
相关概念视频
Prescription, Nonprescription and Orphan Drugs
665
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
665
Drug Administration and Therapy Phases: Overview
391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Factors Influencing Drug Absorption: Disease States and Pharmacology
360
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
360
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K


